Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer DOI Creative Commons
Jaewang Lee, Jong‐Lyel Roh

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Год журнала: 2023, Номер 1869(7), С. 166788 - 166788

Опубликована: Июнь 10, 2023

Язык: Английский

The Metabolic Underpinnings of Ferroptosis DOI Creative Commons
Jiashuo Zheng, Marcus Conrad

Cell Metabolism, Год журнала: 2020, Номер 32(6), С. 920 - 937

Опубликована: Ноя. 20, 2020

Язык: Английский

Процитировано

948

Ferroptosis at the intersection of lipid metabolism and cellular signaling DOI Creative Commons
Deguang Liang, Alexander M. Minikes, Xuejun Jiang

и другие.

Molecular Cell, Год журнала: 2022, Номер 82(12), С. 2215 - 2227

Опубликована: Апрель 6, 2022

Язык: Английский

Процитировано

628

Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention DOI Creative Commons
Lisa M. Butler, Ylenia Perone, Jonas Dehairs

и другие.

Advanced Drug Delivery Reviews, Год журнала: 2020, Номер 159, С. 245 - 293

Опубликована: Янв. 1, 2020

With the advent of effective tools to study lipids, including mass spectrometry-based lipidomics, lipids are emerging as central players in cancer biology. Lipids function essential building blocks for membranes, serve fuel drive energy-demanding processes and play a key role signaling molecules regulators numerous cellular functions. Not unexpectedly, cells, well other cell types tumor microenvironment, exploit various ways acquire extensively rewire their metabolism part plastic context-dependent metabolic reprogramming that is driven by both oncogenic environmental cues. The resulting changes fate composition help cells thrive changing microenvironment supporting functions hallmarks, energetics, promoting feedforward signaling, resisting oxidative stresses, regulating intercellular communication immune responses. Supported close connection between altered lipid pathogenic process, specific profiles unique disease biomarkers, with diagnostic, prognostic predictive potential. Multiple preclinical studies illustrate translational promise exploiting cancer, critically, have shown context dependent actionable vulnerabilities can be rationally targeted, particularly combinatorial approaches. Moreover, themselves used membrane disrupting agents or components nanocarriers therapeutics. number compounds strategies approaching clinical trials, we at doorstep hitherto underappreciated hallmark promising target oncologist's strategy combat cancer.

Язык: Английский

Процитировано

465

Peroxidation of n-3 and n-6 polyunsaturated fatty acids in the acidic tumor environment leads to ferroptosis-mediated anticancer effects DOI Creative Commons
Emeline Dierge,

Elena Debock,

Céline Guilbaud

и другие.

Cell Metabolism, Год журнала: 2021, Номер 33(8), С. 1701 - 1715.e5

Опубликована: Июнь 11, 2021

Язык: Английский

Процитировано

326

Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy DOI Creative Commons
Fan Yang, Yi Xiao, Jia-Han Ding

и другие.

Cell Metabolism, Год журнала: 2022, Номер 35(1), С. 84 - 100.e8

Опубликована: Окт. 17, 2022

Treatment of triple-negative breast cancer (TNBC) remains challenging. Deciphering the orchestration metabolic pathways in regulating ferroptosis will provide new insights into TNBC therapeutic strategies. Here, we integrated multiomics data our large cohort (n = 465) to develop atlas. We discovered that TNBCs had heterogeneous phenotypes ferroptosis-related metabolites and pathways. The luminal androgen receptor (LAR) subtype was characterized by upregulation oxidized phosphatidylethanolamines glutathione metabolism (especially GPX4), which allowed utilization GPX4 inhibitors induce ferroptosis. Furthermore, verified inhibition not only induced tumor but also enhanced antitumor immunity. combination anti-PD1 possessed greater efficacy than monotherapy. Clinically, higher expression correlated with lower cytolytic scores worse prognosis immunotherapy cohorts. Collectively, this study demonstrated landscape revealed an innovative strategy for refractory LAR tumors.

Язык: Английский

Процитировано

320

The cell biology of ferroptosis DOI
Scott J. Dixon, James A. Olzmann

Nature Reviews Molecular Cell Biology, Год журнала: 2024, Номер 25(6), С. 424 - 442

Опубликована: Фев. 16, 2024

Язык: Английский

Процитировано

271

Tumour fatty acid metabolism in the context of therapy resistance and obesity DOI
Andrew J. Hoy, Shilpa R. Nagarajan, Lisa M. Butler

и другие.

Nature reviews. Cancer, Год журнала: 2021, Номер 21(12), С. 753 - 766

Опубликована: Авг. 20, 2021

Язык: Английский

Процитировано

259

Regulation of ferroptosis by lipid metabolism DOI Creative Commons

Lauren E. Pope,

Scott J. Dixon

Trends in Cell Biology, Год журнала: 2023, Номер 33(12), С. 1077 - 1087

Опубликована: Июль 3, 2023

Язык: Английский

Процитировано

220

Ferroptosis Inducers Are a Novel Therapeutic Approach for Advanced Prostate Cancer DOI Open Access
Ali Ghoochani, En‐Chi Hsu,

Merve Aslan

и другие.

Cancer Research, Год журнала: 2021, Номер 81(6), С. 1583 - 1594

Опубликована: Янв. 22, 2021

Abstract Ferroptosis is a type of programmed cell death induced by the accumulation lipid peroxidation and reactive oxygen species in cells. It has been recently demonstrated that cancer cells are vulnerable to ferroptosis inducers (FIN). However, therapeutic potential FINs prostate preclinical settings not explored. In this study, we demonstrate mediators ferroptosis, solute carrier family 7 member 11, SLC3A2, glutathione peroxidase, expressed treatment-resistant cancer. We further sensitive two FINs, erastin RSL3. Treatment with RSL3 led significant decrease growth migration vitro significantly delayed tumor vivo, no measurable side effects. Combination or standard-of-care second-generation antiandrogens for advanced halted vivo. These results independently combination as novel strategies Significance: findings reveal induction new strategy monotherapy antiandrogens.

Язык: Английский

Процитировано

217

The diversity and breadth of cancer cell fatty acid metabolism DOI Creative Commons
Shilpa R. Nagarajan, Lisa M. Butler, Andrew J. Hoy

и другие.

Cancer & Metabolism, Год журнала: 2021, Номер 9(1)

Опубликована: Янв. 7, 2021

Tumor cellular metabolism exhibits distinguishing features that collectively enhance biomass synthesis while maintaining redox balance and homeostasis. These attributes reflect the complex interactions between cell-intrinsic factors such as genomic-transcriptomic regulation cell-extrinsic influences, including growth factor nutrient availability. Alongside glucose amino acid metabolism, fatty supports tumorigenesis disease progression through a range of processes membrane biosynthesis, energy storage production, generation signaling intermediates. Here, we highlight complexity in cancer, various inputs outputs intracellular free pool, numerous ways these pathways influence behavior.

Язык: Английский

Процитировано

146